Lynparza Approved to Treat Metastatic HER2-Negative Breast Cancer in Women With BRCA Mutations January 12, 2018 | Lynparza Approved to Treat Metastatic HER2-Negative Breast Cancer in Women With BRCA MutationsSource: BreastCancer.orgPublished on Friday, January 12, 2018
